市場調査レポート

商品コード

有毛細胞白血病治療薬の世界市場 2024-2028

Global hairy cell leukemia therapeutics market 2024-2028

出版日: 2024年07月09日
発行: TechNavio
ページ情報: 英文 146 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 358,925円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 574,280円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

有毛細胞白血病治療薬市場は2023-2028年に1億1,330万米ドル、予測期間中のCAGRは4.49％で成長すると予測されます。

当レポートでは、有毛細胞白血病治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。有毛細胞白血病につながる有害物質への暴露の増加、老人人口の増加、戦略的提携などが市場を牽引しています。

市場範囲
基準年	2024
終了年	2028
予測期間	2024-2028
成長モメンタム	加速
前年比2024年	4.23%
CAGR	4.49%
増分額	1億1,330万米ドル

本調査では、今後数年間の有毛細胞白血病治療薬市場成長を牽引する主な要因の1つとして、血液がんに対する研究助成金の増加を挙げています。また、新規治療や特効薬の登場は、市場の大きな需要につながります。

地域別セグメンテーション
地域別比較
北米：市場規模と予測 2023-2028
欧州：市場規模と予測 2023-2028
アジア：市場規模と予測 2023-2028
世界のその他の地域：市場規模と予測 2023-2028
米国：市場規模と予測 2023-2028
ドイツ：市場規模と予測 2023-2028
中国：市場規模と予測 2023-2028
カナダ：市場規模と予測 2023-2028
インド：市場規模と予測 2023-2028
市場機会：地域情勢別

第9章促進要因・課題・機会・抑制要因

市場促進要因
市場の課題
促進要因と課題の影響
市場の機会・抑制要因

第10章競合情勢

概要
競合情勢
混乱の状況
業界のリスク

第11章競合分析

企業プロファイル
企業の市場ポジショニング
AbbVie Inc.
Amgen Inc.
AstraZeneca Plc
F. Hoffmann La Roche Ltd.
Fresenius SE and Co. KGaA
Hikma Pharmaceuticals Plc
Innate Pharma SA
Merck KGaA
Pfizer Inc.
Viatris Inc.

第12章付録

図表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global Hairy Cell Leukemia Therapeutics Market 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Product - Market share 2023-2028 (%)
Exhibits31: Data Table on Product - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits45: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits46: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits47: Chart on Geographic comparison
Exhibits48: Data Table on Geographic comparison
Exhibits49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits55: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits59: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits85: Market opportunity By Geographical Landscape ($ million)
Exhibits86: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2023 and 2028
Exhibits88: Overview on criticality of inputs and factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Companies covered
Exhibits92: Matrix on companies position and classification
Exhibits93: AbbVie Inc. - Overview
Exhibits94: AbbVie Inc. - Product / Service
Exhibits95: AbbVie Inc. - Key news
Exhibits96: AbbVie Inc. - Key offerings
Exhibits97: Amgen Inc. - Overview
Exhibits98: Amgen Inc. - Product / Service
Exhibits99: Amgen Inc. - Key news
Exhibits100: Amgen Inc. - Key offerings
Exhibits101: AstraZeneca Plc - Overview
Exhibits102: AstraZeneca Plc - Product / Service
Exhibits103: AstraZeneca Plc - Key news
Exhibits104: AstraZeneca Plc - Key offerings
Exhibits105: F. Hoffmann La Roche Ltd. - Overview
Exhibits106: F. Hoffmann La Roche Ltd. - Business segments
Exhibits107: F. Hoffmann La Roche Ltd. - Key news
Exhibits108: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits109: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits110: Fresenius SE and Co. KGaA - Overview
Exhibits111: Fresenius SE and Co. KGaA - Business segments
Exhibits112: Fresenius SE and Co. KGaA - Key news
Exhibits113: Fresenius SE and Co. KGaA - Key offerings
Exhibits114: Fresenius SE and Co. KGaA - Segment focus
Exhibits115: Hikma Pharmaceuticals Plc - Overview
Exhibits116: Hikma Pharmaceuticals Plc - Business segments
Exhibits117: Hikma Pharmaceuticals Plc - Key news
Exhibits118: Hikma Pharmaceuticals Plc - Key offerings
Exhibits119: Hikma Pharmaceuticals Plc - Segment focus
Exhibits120: Innate Pharma SA - Overview
Exhibits121: Innate Pharma SA - Product / Service
Exhibits122: Innate Pharma SA - Key offerings
Exhibits123: Merck KGaA - Overview
Exhibits124: Merck KGaA - Business segments
Exhibits125: Merck KGaA - Key news
Exhibits126: Merck KGaA - Key offerings
Exhibits127: Merck KGaA - Segment focus
Exhibits128: Pfizer Inc. - Overview
Exhibits129: Pfizer Inc. - Product / Service
Exhibits130: Pfizer Inc. - Key news
Exhibits131: Pfizer Inc. - Key offerings
Exhibits132: Viatris Inc. - Overview
Exhibits133: Viatris Inc. - Business segments
Exhibits134: Viatris Inc. - Key news
Exhibits135: Viatris Inc. - Key offerings
Exhibits136: Viatris Inc. - Segment focus
Exhibits137: Inclusions checklist
Exhibits138: Exclusions checklist
Exhibits139: Currency conversion rates for US$
Exhibits140: Research methodology
Exhibits141: Information sources
Exhibits142: Data validation
Exhibits143: Validation techniques employed for market sizing
Exhibits144: Data synthesis
Exhibits145: 360 degree market analysis
Exhibits146: List of abbreviations

Product Code: IRTNTR73600

The hairy cell leukemia therapeutics market is forecasted to grow by USD 113.3 mn during 2023-2028, accelerating at a CAGR of 4.49% during the forecast period. The report on the hairy cell leukemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing exposure to hazardous substances leading to hairy cell leukemia, growing geriatric population, and strategic alliances.

Technavio's hairy cell leukemia therapeutics market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	4.23%
CAGR	4.49%
Incremental Value	$113.3mn

By Product

Chemotherapy
Targeted therapy

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing research grants for blood cancers as one of the prime reasons driving the hairy cell leukemia therapeutics market growth during the next few years. Also, advent of novel therapies and special drug designations will lead to sizable demand in the market.

The report on the hairy cell leukemia therapeutics market covers the following areas:

Hairy cell leukemia therapeutics market sizing
Hairy cell leukemia therapeutics market forecast
Hairy cell leukemia therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hairy cell leukemia therapeutics market vendors that include AbbVie Inc., Amgen Inc., Astex Pharmaceuticals Inc., AstraZeneca Plc, Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Hikma Pharmaceuticals Plc, Innate Pharma SA, Merck KGaA, Pfizer Inc., and Viatris Inc.. Also, the hairy cell leukemia therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Hairy Cell Leukemia Therapeutics Market 2018 - 2022
- Historic Market Size - Data Table on Global Hairy Cell Leukemia Therapeutics Market 2018 - 2022 ($ million)
4.2 Product segment analysis 2018 - 2022
- Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
- Chart on Product - Market share 2023-2028 (%)
- Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
6.3 Chemotherapy - Market size and forecast 2023-2028
- Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
- Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
- Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
- Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
6.4 Targeted therapy - Market size and forecast 2023-2028
- Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million)
- Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million)
- Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
- Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

7 Customer Landscape

7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
8.10 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.11 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints

10 Competitive Landscape

10.1 Overview
10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
- Overview on factors of disruption
10.4 Industry risks
- Impact of key risks on business

11 Competitive Analysis

11.1 Companies profiled
- Companies covered
11.2 Market positioning of companies
- Matrix on companies position and classification
11.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
11.4 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
11.5 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
11.6 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
11.7 Fresenius SE and Co. KGaA
- Fresenius SE and Co. KGaA - Overview
- Fresenius SE and Co. KGaA - Business segments
- Fresenius SE and Co. KGaA - Key news
- Fresenius SE and Co. KGaA - Key offerings
- Fresenius SE and Co. KGaA - Segment focus
11.8 Hikma Pharmaceuticals Plc
- Hikma Pharmaceuticals Plc - Overview
- Hikma Pharmaceuticals Plc - Business segments
- Hikma Pharmaceuticals Plc - Key news
- Hikma Pharmaceuticals Plc - Key offerings
- Hikma Pharmaceuticals Plc - Segment focus
11.9 Innate Pharma SA
- Innate Pharma SA - Overview
- Innate Pharma SA - Product / Service
- Innate Pharma SA - Key offerings
11.10 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
11.11 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
11.12 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus

12 Appendix

12.1 Scope of the report
12.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
12.3 Currency conversion rates for US$
- Currency conversion rates for US$
12.4 Research methodology
- Research methodology
12.5 Data procurement
- Information sources
12.6 Data validation
- Data validation
12.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
12.8 Data synthesis
- Data synthesis
12.9 360 degree market analysis
- 360 degree market analysis
12.10 List of abbreviations
- List of abbreviations

有毛細胞白血病治療薬の世界市場 2024-2028

Global hairy cell leukemia therapeutics market 2024-2028

目次

第1章エグゼクティブサマリー

第2章市場情勢

第3章市場規模の評価

第4章市場規模実績

第5章ファイブフォース分析

第6章市場セグメンテーション：製品別

第7章顧客情勢

第8章地域別情勢

第9章促進要因・課題・機会・抑制要因

第10章競合情勢

第11章競合分析

第12章付録

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Product

7 Customer Landscape

8 Geographic Landscape

9 Drivers, Challenges, and Opportunity/Restraints

10 Competitive Landscape

11 Competitive Analysis

12 Appendix

有毛細胞白血病治療薬の世界市場 2024-2028

Global hairy cell leukemia therapeutics market 2024-2028

目次

第1章 エグゼクティブサマリー

第2章 市場情勢

第3章 市場規模の評価

第4章 市場規模実績

第5章 ファイブフォース分析

第6章 市場セグメンテーション：製品別

第7章 顧客情勢

第8章 地域別情勢

第9章 促進要因・課題・機会・抑制要因

第10章 競合情勢

第11章 競合分析

第12章 付録

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Product

7 Customer Landscape

8 Geographic Landscape

9 Drivers, Challenges, and Opportunity/Restraints

10 Competitive Landscape

11 Competitive Analysis

12 Appendix

第1章エグゼクティブサマリー

第2章市場情勢

第3章市場規模の評価

第4章市場規模実績

第5章ファイブフォース分析

第6章市場セグメンテーション：製品別

第7章顧客情勢

第8章地域別情勢

第9章促進要因・課題・機会・抑制要因

第10章競合情勢

第11章競合分析

第12章付録